| Name | Title | Contact Details |
|---|
Hale Ho Aloha Icf is a Honolulu, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Wellnet Healthcare is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Carta empowers hospitals to personalize the delivery of care to the individual needs of each patient. Our insight here is that personalizing care is not only good from an outcome/clinical perspective (where most people focus in the context of personalization) but is also the best way to optimize operations. Currently, hospitals have to over provision their resources because they are set up to serve the generic patient; planning ahead for exactly the resources needed– no more, no less– is the best way to gain efficiency. The approach we`re advocating and enabling is to: 1) Find past patients similar to the current one being treated 2) Quantify what exactly happened to them during their journey through the hospital (this is where our model comes in) 3) Use machine learning to project what the particular patient in question will need, and what the patient can expect their experience to be in the hospital We`re applying this approach now to two use cases– supplies projection and bed usage projection– and we have a bunch of other use cases we`re planning on addressing in the future.
Airborne Critical Care is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.